Immunotherapy, Passive

Known as: Immunotherapies, Passive, Passive Immunotherapies, Passive Immunotherapy 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Venezuelan equine encephalitis virus (VEEV) is a mosquito-borne RNA virus that causes low mortality but high morbidity rates in… (More)
  • table 1
  • table 3
Is this relevant?
Review
2016
Review
2016
INTRODUCTION Outcome for glioma (GBM) remains dismal despite advances in therapeutic interventions including chemotherapy… (More)
  • figure 2
  • table 2
  • table 3
Is this relevant?
Review
2016
Review
2016
Epithelial ovarian cancer (EOC) is the most lethal gynecological cancer. Several approaches of active and passive immunotherapy… (More)
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2014
2014
The recent outbreak of infections with Ebola virus (EV) in West Africa caused already over 4000 deaths and is rapidly increasing… (More)
Is this relevant?
Review
2014
Review
2014
Passive immunotherapy with monoclonal antibodies is an indispensable cornerstone of clinical oncology. Notably, all FDA-approved… (More)
  • figure 1
  • table 1
  • table 3
Is this relevant?
2009
2009
Passive immunotherapy (PI) is being explored as a potential therapeutic against Alzheimer's disease. The most promising… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
2009
2009
Passive immunotherapy (PI) is being explored as a potential therapeutic against Alzheimer’s disease. The most promising… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
1998
1998
We have been treating patients with advanced HIV disease using passive immunotherapy (PIT). Earlier studies of PIT which have… (More)
Is this relevant?
1998
1998
  • TreatmentUpdate
  • 1998
Some researchers believe that anti-HIV antibodies have a role in controlling HIV infection. A study involving passive… (More)
Is this relevant?
1998
1998
  • TreatmentUpdate
  • 1998
Removing protective antibodies from healthy, symptom-free, HIV-positive people does not appear to have a negative impact on… (More)
Is this relevant?